{"id":407607,"date":"2021-01-04T09:17:28","date_gmt":"2021-01-04T14:17:28","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=407607"},"modified":"2021-01-04T09:17:28","modified_gmt":"2021-01-04T14:17:28","slug":"novo-nordisk-extends-covid-19-patient-assistance-program-encourages-people-facing-affordability-challenges-to-visit-novocare-com","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/novo-nordisk-extends-covid-19-patient-assistance-program-encourages-people-facing-affordability-challenges-to-visit-novocare-com\/","title":{"rendered":"Novo Nordisk extends COVID-19 Patient Assistance Program, encourages people facing affordability challenges to visit NovoCare.com"},"content":{"rendered":"<div class=\"xn-newslines\">\n<h2 class=\"xn-hedline\">&#8211; COVID-19 Patient Assistance Program: Eligible patients can continue to enroll in our Diabetes Patient Assistance Program and receive a free 90-day supply of insulin until June 30, 2021<\/h2>\n<h2 class=\"xn-hedline\">&#8211; My$99Insulin Program: Patients who enrolled in the cash card program in 2020 must reregister to determine if they are eligible to continue participating in 2021<\/h2>\n<h2 class=\"xn-hedline\">&#8211; Patients facing affordability challenges for any reason are encouraged to visit NovoCare.com to learn about our programs that may be able to help<\/h2>\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"xn-location\">PLAINSBORO, N.J.<\/span>, <span class=\"xn-chron\">Jan. 4, 2021<\/span> \/PRNewswire\/ &#8212;\u00a0Today, Novo Nordisk announced the extension of its <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3024807-1&amp;h=2739048562&amp;u=https%3A%2F%2Fwww.novocare.com%2F%23commitment&amp;a=COVID-19+Patient+Assistance+Program\" rel=\"nofollow noopener noreferrer\">COVID-19 Patient Assistance Program<\/a> until <span class=\"xn-chron\">June 30, 2021<\/span>, for those who have lost health insurance coverage because of a change in job status due to the pandemic. <\/p>\n<p>The company also would like to remind people who are currently using the <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3024807-1&amp;h=750708965&amp;u=https%3A%2F%2Fwww.novocare.com%2Fcontent%2Fnovocare%2Fen%2Finsulin%2Fmy99insulin.html&amp;a=My%2499Insulin+program\" rel=\"nofollow noopener noreferrer\">My$99Insulin program<\/a> that they must reregister to determine if they are eligible for the cash card program.<\/p>\n<p>For people looking to find out what option makes the most sense for their particular situation, information and eligibility criteria about these and other offerings are available online at <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3024807-1&amp;h=1814183688&amp;u=http%3A%2F%2Fnovocare.com%2F&amp;a=NovoCare.com\" rel=\"nofollow noopener noreferrer\">NovoCare.com<\/a> or by calling 1.844.NOVO4ME (1.844.668.6463).<\/p>\n<p>&#8220;Last January, we created new programs to meet the varying needs of patients whether they have insurance or don&#8217;t and made them available on Novocare.com. Then, the pandemic hit and patients faced new challenges &#8211; millions of people lost their jobs and very likely their health coverage so we knew we needed to do more specific to the pandemic,&#8221; said\u00a0Doug Langa, Executive Vice President, North America Operations\u00a0and President of Novo Nordisk Inc. &#8220;The need is still present &#8211; our nation is not back to normal and our economic and public health reality is still challenging. So, we&#8217;re continuing our COVID -19 assistance program and encouraging anyone facing affordability challenges to visit our one-stop support resource to find the option most suitable to them.&#8221;<\/p>\n<p>\n        <b>Important updates in Novo Nordisk&#8217;s affordability programs<\/b>\n      <\/p>\n<ul type=\"disc\">\n<li>\n          <b>COVID-19 Patient Assistance Program:<\/b> Launched in <span class=\"xn-chron\">April 2020<\/span>, people with diabetes using Novo Nordisk insulin who lost health insurance coverage because of a change in job status due to the COVID-19 pandemic could enroll in our Diabetes Patient Assistance Program (PAP) and receive insulin free of charge for 90 days. The program has been extended until <span class=\"xn-chron\">June 30, 2021<\/span>. Eligibility criteria can be found on NovoCare.com or by calling 1.844.NOVO4ME (668.6463) <\/li>\n<li>\n          <b>My$99Insulin:<\/b> My$99Insulin enables eligible patients to purchase up to three vials or two packs of FlexPen<sup>\u00ae<\/sup>\/FlexTouch<sup>\u00ae<\/sup>\/PenFill<sup>\u00ae<\/sup> pens of any combination of insulins for <span class=\"xn-money\">$99<\/span>. Patients who enrolled in the My$99 Insulin program in 2020 should review the details of the program on NovoCare.com to determine if they are eligible to re-register in 2021<\/li>\n<\/ul>\n<p>Novo Nordisk offers a number of other affordability programs, including: <\/p>\n<ul type=\"disc\">\n<li>Our long-standing <b>Patient Assistance Program (PAP)<\/b>, which has provided free medicines to eligible patients since 2003, has been enhanced to reflect today&#8217;s public health crisis. Historically, more than 50,000 patients have received free insulin each year through this program. Effective <span class=\"xn-chron\">April 1, 2020<\/span>, Medicare patients who qualify for PAP are no longer required to pay <span class=\"xn-money\">$1,000<\/span> for medicines before being eligible for the Novo Nordisk PAP <\/li>\n<li>\n          <b>Unbranded biologic insulins:<\/b> Unbranded biologics of NovoLog<sup>\u00ae<\/sup> and NovoLog<sup>\u00ae<\/sup> Mix, from Novo Nordisk Pharma, Inc. (NNPI), a Novo Nordisk A\/S US company, can be ordered at one&#8217;s local pharmacy and cost 50 percent off the current list prices of the branded medicines <\/li>\n<li>\n          <b>Immediate Supply:<\/b> We also know that there may be instances when people are struggling and need insulin immediately because they might be at risk of rationing. People in this situation can call us at 1.844.NOVO4ME (1.844.668.6463) or visit NovoCare.com to see if we can provide a free, one-time, immediate supply of up to three vials or two packs of pens of Novo Nordisk insulin for individuals with a prescription <\/li>\n<li>\n          <b>Novo Nordisk human insulin <\/b>is available at national pharmacies like Walmart and CVS for about <span class=\"xn-money\">$25<\/span>\/vial. About 500,000 Americans are using Novo Nordisk human insulin through these retailers <\/li>\n<li>\n          <b>Copay Savings Cards <\/b>can help defray the costs for commercially insured patients who are experiencing high out-of-pocket costs<\/li>\n<\/ul>\n<p>To learn more about these offerings and view full eligibility requirements, please visit <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3024807-1&amp;h=1814183688&amp;u=http%3A%2F%2Fnovocare.com%2F&amp;a=NovoCare.com\" rel=\"nofollow noopener noreferrer\">NovoCare.com<\/a>.<\/p>\n<p>Additionally, we&#8217;ll continue working towards longer-term reform that makes it easier for people who need our medicines to get them. For instance, we advocate that payers adopt a 2019 IRS rule classifying insulin as preventive care, which could help a significant number of people overcome affordability barriers.\u00a0 <\/p>\n<p>\n        <b>About NovoCare.com<br \/><\/b>NovoCare.com is Novo Nordisk&#8217;s go-to resource for all US patient affordability and access support programs. Available 24 hours a day, NovoCare.com provides all necessary information, including eligibility details, affordability options, assistance programs for those in need of insulin. Help is also available at 1.844.NOVO4ME (668.6463).<\/p>\n<p>\n        <b>About Novo Nordisk Inc. (NNI)<br \/><\/b>NNI is a US affiliate of Novo Nordisk. The company is based in\u00a0Plainsboro, NJ\u00a0and is responsible for commercialization of Novo Nordisk brands in the US and management of clinical trials in the US. For more information, visit\u00a0<u><a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3024807-1&amp;h=988932000&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2679982-1%26h%3D1076803878%26u%3Dhttps%253A%252F%252Fc212.net%252Fc%252Flink%252F%253Ft%253D0%2526l%253Den%2526o%253D2552173-1%2526h%253D646777574%2526u%253Dhttps%25253A%25252F%25252Fc212.net%25252Fc%25252Flink%25252F%25253Ft%25253D0%252526l%25253Den%252526o%25253D2451518-1%252526h%25253D2387488323%252526u%25253Dhttp%2525253A%2525252F%2525252Fwww.novonordisk-us.com%2525252F%252526a%25253Dnovonordisk.us%2526a%253Dnovonordisk.us%26a%3Dnovonordisk.us&amp;a=novonordisk.us\" rel=\"nofollow noopener noreferrer\">novonordisk.us<\/a><\/u>,\u00a0<u><a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3024807-1&amp;h=3069396421&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2679982-1%26h%3D3442393283%26u%3Dhttps%253A%252F%252Fc212.net%252Fc%252Flink%252F%253Ft%253D0%2526l%253Den%2526o%253D2552173-1%2526h%253D2440158699%2526u%253Dhttps%25253A%25252F%25252Fc212.net%25252Fc%25252Flink%25252F%25253Ft%25253D0%252526l%25253Den%252526o%25253D2451518-1%252526h%25253D2472373306%252526u%25253Dhttps%2525253A%2525252F%2525252Fwww.facebook.com%2525252FNovoNordiskUS%2525252F%252526a%25253DFacebook%2526a%253DFacebook%26a%3DFacebook&amp;a=Facebook\" rel=\"nofollow noopener noreferrer\">Facebook<\/a><\/u>,\u00a0<u><a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3024807-1&amp;h=1206949593&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2679982-1%26h%3D2375383347%26u%3Dhttps%253A%252F%252Fc212.net%252Fc%252Flink%252F%253Ft%253D0%2526l%253Den%2526o%253D2552173-1%2526h%253D4103895002%2526u%253Dhttps%25253A%25252F%25252Fc212.net%25252Fc%25252Flink%25252F%25253Ft%25253D0%252526l%25253Den%252526o%25253D2451518-1%252526h%25253D4259884890%252526u%25253Dhttps%2525253A%2525252F%2525252Fwww.instagram.com%2525252Fnovonordiskus%2525252F%252526a%25253DInstagram%2526a%253DInstagram%26a%3DInstagram&amp;a=Instagram\" rel=\"nofollow noopener noreferrer\">Instagram<\/a><\/u>\u00a0and\u00a0<u><a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3024807-1&amp;h=1053689423&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2679982-1%26h%3D3981592603%26u%3Dhttps%253A%252F%252Fc212.net%252Fc%252Flink%252F%253Ft%253D0%2526l%253Den%2526o%253D2552173-1%2526h%253D1621330498%2526u%253Dhttps%25253A%25252F%25252Fc212.net%25252Fc%25252Flink%25252F%25253Ft%25253D0%252526l%25253Den%252526o%25253D2451518-1%252526h%25253D2124259418%252526u%25253Dhttps%2525253A%2525252F%2525252Ftwitter.com%2525252Fnovonordiskus%252526a%25253DTwitter%2526a%253DTwitter%26a%3DTwitter&amp;a=Twitter\" rel=\"nofollow noopener noreferrer\">Twitter<\/a><\/u>.<\/p>\n<p>\n        <b>About Novo Nordisk Pharma, Inc.\u00a0(NNPI)<br \/><\/b>Novo Nordisk Pharma, Inc. (NNPI) is a newly established Novo Nordisk A\/S US company that is also based in\u00a0Plainsboro, NJ. The company was formed in\u00a0March 2019\u00a0to bring unbranded biologics of Novo Nordisk insulin products at a reduced list price for people facing affordability challenges.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder2055\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/1393815\/Novo_Nordisk_White_Blue_Logo.html\" target=\"_blank\" rel=\"nofollow noopener noreferrer\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/1393815\/Novo_Nordisk_White_Blue_Logo.jpg\" title=\"Novo Nordisk Inc.\" alt=\"Novo Nordisk Inc.\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>\u00a0<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder0\"><\/div>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=PH36094&amp;sd=2021-01-04\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"http:\/\/www.prnewswire.com\/news-releases\/novo-nordisk-extends-covid-19-patient-assistance-program-encourages-people-facing-affordability-challenges-to-visit-novocarecom-301200105.html\">http:\/\/www.prnewswire.com\/news-releases\/novo-nordisk-extends-covid-19-patient-assistance-program-encourages-people-facing-affordability-challenges-to-visit-novocarecom-301200105.html<\/a><\/p>\n<p>SOURCE  Novo Nordisk<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=PH36094&amp;Transmission_Id=202101040914PR_NEWS_USPR_____PH36094&amp;DateId=20210104\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>&#8211; COVID-19 Patient Assistance Program: Eligible patients can continue to enroll in our Diabetes Patient Assistance Program and receive a free 90-day supply of insulin until June 30, 2021 &#8211; My$99Insulin Program: Patients who enrolled in the cash card program in 2020 must reregister to determine if they are eligible to continue participating in 2021 &#8211; Patients facing affordability challenges for any reason are encouraged to visit NovoCare.com to learn about our programs that may be able to help PR Newswire PLAINSBORO, N.J., Jan. 4, 2021 \/PRNewswire\/ &#8212;\u00a0Today, Novo Nordisk announced the extension of its COVID-19 Patient Assistance Program until June 30, 2021, for those who have lost health insurance coverage because of a change in job status due to &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/novo-nordisk-extends-covid-19-patient-assistance-program-encourages-people-facing-affordability-challenges-to-visit-novocare-com\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Novo Nordisk extends COVID-19 Patient Assistance Program, encourages people facing affordability challenges to visit NovoCare.com&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-407607","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Novo Nordisk extends COVID-19 Patient Assistance Program, encourages people facing affordability challenges to visit NovoCare.com - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/novo-nordisk-extends-covid-19-patient-assistance-program-encourages-people-facing-affordability-challenges-to-visit-novocare-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Novo Nordisk extends COVID-19 Patient Assistance Program, encourages people facing affordability challenges to visit NovoCare.com - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"&#8211; COVID-19 Patient Assistance Program: Eligible patients can continue to enroll in our Diabetes Patient Assistance Program and receive a free 90-day supply of insulin until June 30, 2021 &#8211; My$99Insulin Program: Patients who enrolled in the cash card program in 2020 must reregister to determine if they are eligible to continue participating in 2021 &#8211; Patients facing affordability challenges for any reason are encouraged to visit NovoCare.com to learn about our programs that may be able to help PR Newswire PLAINSBORO, N.J., Jan. 4, 2021 \/PRNewswire\/ &#8212;\u00a0Today, Novo Nordisk announced the extension of its COVID-19 Patient Assistance Program until June 30, 2021, for those who have lost health insurance coverage because of a change in job status due to &hellip; Continue reading &quot;Novo Nordisk extends COVID-19 Patient Assistance Program, encourages people facing affordability challenges to visit NovoCare.com&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/novo-nordisk-extends-covid-19-patient-assistance-program-encourages-people-facing-affordability-challenges-to-visit-novocare-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-04T14:17:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/1393815\/Novo_Nordisk_White_Blue_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novo-nordisk-extends-covid-19-patient-assistance-program-encourages-people-facing-affordability-challenges-to-visit-novocare-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novo-nordisk-extends-covid-19-patient-assistance-program-encourages-people-facing-affordability-challenges-to-visit-novocare-com\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Novo Nordisk extends COVID-19 Patient Assistance Program, encourages people facing affordability challenges to visit NovoCare.com\",\"datePublished\":\"2021-01-04T14:17:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novo-nordisk-extends-covid-19-patient-assistance-program-encourages-people-facing-affordability-challenges-to-visit-novocare-com\\\/\"},\"wordCount\":915,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novo-nordisk-extends-covid-19-patient-assistance-program-encourages-people-facing-affordability-challenges-to-visit-novocare-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1393815\\\/Novo_Nordisk_White_Blue_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novo-nordisk-extends-covid-19-patient-assistance-program-encourages-people-facing-affordability-challenges-to-visit-novocare-com\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novo-nordisk-extends-covid-19-patient-assistance-program-encourages-people-facing-affordability-challenges-to-visit-novocare-com\\\/\",\"name\":\"Novo Nordisk extends COVID-19 Patient Assistance Program, encourages people facing affordability challenges to visit NovoCare.com - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novo-nordisk-extends-covid-19-patient-assistance-program-encourages-people-facing-affordability-challenges-to-visit-novocare-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novo-nordisk-extends-covid-19-patient-assistance-program-encourages-people-facing-affordability-challenges-to-visit-novocare-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1393815\\\/Novo_Nordisk_White_Blue_Logo.jpg\",\"datePublished\":\"2021-01-04T14:17:28+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novo-nordisk-extends-covid-19-patient-assistance-program-encourages-people-facing-affordability-challenges-to-visit-novocare-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novo-nordisk-extends-covid-19-patient-assistance-program-encourages-people-facing-affordability-challenges-to-visit-novocare-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novo-nordisk-extends-covid-19-patient-assistance-program-encourages-people-facing-affordability-challenges-to-visit-novocare-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1393815\\\/Novo_Nordisk_White_Blue_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1393815\\\/Novo_Nordisk_White_Blue_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novo-nordisk-extends-covid-19-patient-assistance-program-encourages-people-facing-affordability-challenges-to-visit-novocare-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Novo Nordisk extends COVID-19 Patient Assistance Program, encourages people facing affordability challenges to visit NovoCare.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Novo Nordisk extends COVID-19 Patient Assistance Program, encourages people facing affordability challenges to visit NovoCare.com - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/novo-nordisk-extends-covid-19-patient-assistance-program-encourages-people-facing-affordability-challenges-to-visit-novocare-com\/","og_locale":"en_US","og_type":"article","og_title":"Novo Nordisk extends COVID-19 Patient Assistance Program, encourages people facing affordability challenges to visit NovoCare.com - Market Newsdesk","og_description":"&#8211; COVID-19 Patient Assistance Program: Eligible patients can continue to enroll in our Diabetes Patient Assistance Program and receive a free 90-day supply of insulin until June 30, 2021 &#8211; My$99Insulin Program: Patients who enrolled in the cash card program in 2020 must reregister to determine if they are eligible to continue participating in 2021 &#8211; Patients facing affordability challenges for any reason are encouraged to visit NovoCare.com to learn about our programs that may be able to help PR Newswire PLAINSBORO, N.J., Jan. 4, 2021 \/PRNewswire\/ &#8212;\u00a0Today, Novo Nordisk announced the extension of its COVID-19 Patient Assistance Program until June 30, 2021, for those who have lost health insurance coverage because of a change in job status due to &hellip; Continue reading \"Novo Nordisk extends COVID-19 Patient Assistance Program, encourages people facing affordability challenges to visit NovoCare.com\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/novo-nordisk-extends-covid-19-patient-assistance-program-encourages-people-facing-affordability-challenges-to-visit-novocare-com\/","og_site_name":"Market Newsdesk","article_published_time":"2021-01-04T14:17:28+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/1393815\/Novo_Nordisk_White_Blue_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novo-nordisk-extends-covid-19-patient-assistance-program-encourages-people-facing-affordability-challenges-to-visit-novocare-com\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novo-nordisk-extends-covid-19-patient-assistance-program-encourages-people-facing-affordability-challenges-to-visit-novocare-com\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Novo Nordisk extends COVID-19 Patient Assistance Program, encourages people facing affordability challenges to visit NovoCare.com","datePublished":"2021-01-04T14:17:28+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novo-nordisk-extends-covid-19-patient-assistance-program-encourages-people-facing-affordability-challenges-to-visit-novocare-com\/"},"wordCount":915,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novo-nordisk-extends-covid-19-patient-assistance-program-encourages-people-facing-affordability-challenges-to-visit-novocare-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1393815\/Novo_Nordisk_White_Blue_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novo-nordisk-extends-covid-19-patient-assistance-program-encourages-people-facing-affordability-challenges-to-visit-novocare-com\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/novo-nordisk-extends-covid-19-patient-assistance-program-encourages-people-facing-affordability-challenges-to-visit-novocare-com\/","name":"Novo Nordisk extends COVID-19 Patient Assistance Program, encourages people facing affordability challenges to visit NovoCare.com - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novo-nordisk-extends-covid-19-patient-assistance-program-encourages-people-facing-affordability-challenges-to-visit-novocare-com\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novo-nordisk-extends-covid-19-patient-assistance-program-encourages-people-facing-affordability-challenges-to-visit-novocare-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1393815\/Novo_Nordisk_White_Blue_Logo.jpg","datePublished":"2021-01-04T14:17:28+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novo-nordisk-extends-covid-19-patient-assistance-program-encourages-people-facing-affordability-challenges-to-visit-novocare-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/novo-nordisk-extends-covid-19-patient-assistance-program-encourages-people-facing-affordability-challenges-to-visit-novocare-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novo-nordisk-extends-covid-19-patient-assistance-program-encourages-people-facing-affordability-challenges-to-visit-novocare-com\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/1393815\/Novo_Nordisk_White_Blue_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/1393815\/Novo_Nordisk_White_Blue_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novo-nordisk-extends-covid-19-patient-assistance-program-encourages-people-facing-affordability-challenges-to-visit-novocare-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Novo Nordisk extends COVID-19 Patient Assistance Program, encourages people facing affordability challenges to visit NovoCare.com"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/407607","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=407607"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/407607\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=407607"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=407607"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=407607"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}